Even relatively simple procedures widely used to monitor drug safety (such as routine tests of hepatic function) are not yet widely available in resource poor settings. Acknowledging this state of affairs in its current guidelines for HIV treatment in resource poor settings, the World Health Organization indicates that it “recognizes the importance of laboratory monitoring for efficacy and safety but does not want restricted infrastructure for these tests to place undue limitations on the scale-up effort.”4